- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06619821
Effects of Parent-Adolescent Joint Interventions for Adolescents With Adverse Childhood Experiences (EASY-PEP)
Effects of Parent-Adolescent Joint Interventions for Adolescents With Adverse Childhood Experiences: A Multi-Center Cluster Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hebei
-
Baoding, Hebei, China
- Diannan middle school
-
Baoding, Hebei, China
- Biancun middle school
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Middle school students studying in school and their parents
- Capable of hearing, speaking, reading, and writing
Exclusion Criteria:
- High suicidal risks
- Severe mental disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Psychoeducation group (PsyE)
Psychoeducation consists of parent and adolescent psychoeducation.
The content includes an introduction to stress, emotional distress and mental disorders.
|
Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders.
The content provides foundational knowledge to help participants understand and manage these challenges.
|
|
Experimental: Psychoeducation + Emotional Skills (PsyE+EmoS)
Psychoeducation includes sessions for both parents and adolescents, offering the same content as the control group, which introduces stress, emotional distress, and mental disorders. In addition, the emotional skills enhancement sessions provide online materials focused on emotional awareness and emotion regulation strategies, along with tasks related to the content. Participants will also be required to complete a weekly writing assignment, upload their written contents, and assess their level of subjective discomfort following each writing exercise. |
Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders.
The content provides foundational knowledge to help participants understand and manage these challenges.
This intervention combines online material with practical, emotion-focused activities.
Participants will receive training on emotional awareness and emotion regulation strategies, along with completing weekly writing assignments.
These assignments focus on recent negative events and the emotions associated with them, encouraging emotional expression and processing.
The intervention requires parents to complete a weekly parent-child interaction task designed to foster positive childhood experiences.
Parents will engage in structured activities with their children and document the interactions.
Each week, they are expected to upload a report.
|
|
Experimental: Psychoeducation + emotional skills + PCE (PsyE+EmoS+PoCE)
In comparison to the PsyE+EmoS group, this group additionally requires parents to complete a weekly parent-child communication task aimed at fostering positive childhood experiences.
Parents are also expected to document and upload the details of these tasks each week.
|
Psychoeducation includes sessions for both parents and adolescents, covering key topics such as stress, emotional distress, and mental disorders.
The content provides foundational knowledge to help participants understand and manage these challenges.
This intervention combines online material with practical, emotion-focused activities.
Participants will receive training on emotional awareness and emotion regulation strategies, along with completing weekly writing assignments.
These assignments focus on recent negative events and the emotions associated with them, encouraging emotional expression and processing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alexithymia
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 36-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 36 to 180).
A higher score represents more severe alexithymia.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
PTSD for adolescents
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80).
A higher score represents worse PTSD symptoms.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Emotion awareness
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 30-item Emotion awareness questionnaire measures emotion awareness on a 3-point Likert scale (1 to 3, and total scores vary from 30 to 90).
A higher score represents better emotion awareness.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Emotion regulation
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
An 18-item cognitive emotion regulation questionnaire measures the ability of emotion regulation on a 5-point Likert scale (1 to 5, and total scores vary from 18 to 90).
A higher score represents better emotion regulation.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Depression
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The 9-item patient health questionnaire (PHQ-9) for adults (score from 0 to 3, and total score varies from 0 to 27).
A higher score represents worse depression symptoms.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Generalized anxiety disorder
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21).
A higher score represents worse anxiety symptoms.
|
baseline, post treatment(1 month), 3 month after post treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Irritability
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85).
A higher score represents higher irritability.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Resilience
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item resilience measurement scale, the Connor-Davidson resilience scale, measures resilience on a 5-point Likert scale (score from 0 to 4, and total score varies from 0 to 40).
A higher score represents better resilience .
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Seeking for help
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item help-seeking scale measures on a 7-point Likert scale (score from 1 to 7, and total score varies from 10 to 70), with higher scores indicating greater willingness to seek help from others.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Insomnia Severity
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The severity of insomnia symptoms will be assessed using the Insomnia Severity Index (ISI).
This 7-item self-report measurement evaluates the severity of insomnia symptoms, the level of satisfaction with sleep, interference with daily functioning, noticeability of impairment attributed to sleep problems, and the level of distress caused by sleep disturbance (score from 0 to 4, and total score vary from 0 to 32).
Each item is rated on a 5-point scale, providing a comprehensive measure of insomnia severity.
|
baseline, post treatment(1 month), 3 month after post treatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-esteem
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item self-esteemmeasurement scale, Rosenberg self-esteem scale, measures self-esteem on a 4-point Likert scale (score from 0 to 3, and total score varies from 0 to 30), with higher scores indicating greater self-esteem.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Subjective Happiness Scale
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 4-item subjective happiness scale measures happiness (score from 1 to 7, and total score vary from 4 to 28).
A higher score represents a happier state.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Game Addiction Scale
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 7-item game addiction scale, measures game addiction on a 5-point Likert scale (score from 1 to 5, and total score varies from 7 to 35), with higher scores indicating worse game addiction.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Meaning in life
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 6-item meaning in life scale measures life meaning (score from 1 to 5, and total score vary from 6 to 30).
A higher score represents more life meaning perception.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Subjective Units of Distress Scale
Time Frame: each week during intervention (up to 4 months)
|
A single item inquires about subjective distress on a 100-point scale.
A higher score represents more subjective distress.
|
each week during intervention (up to 4 months)
|
|
Suicide
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The suicidal behaviors questionnaire-revised (SBQ-R) for adolescents and children (total scores vary from 3 to 18).
A higher score represents a higher suicide risk.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Social support
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The 12-item Multidimensional Scale of Perceived Social Support (score from 1 to 7, and total score varies from 12 to 84).
A higher score represents better social support.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Positive Childhood Experiences
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A questionnaire measuring positive childhood experiences with 13 items(total scores vary from 0 to 64).
A higher score represents a more positive childhood experiences.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Behavior performances
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 22-item behavior performance questionnaire measures various behavior performances such as study time, phone use, school performance, drinking alcohol, smoking, stealing, fighting, and lying.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Non-suicidal self-injury
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
The non-suicidal self-injury assessment tool (NSSI-AT-Severity) for adolescents and children (total scores vary from 5 to 16).
A higher score represents a worse self-injury situation.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Self-esteem stability
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 5-item Labile Self-Esteem Scale measures self-esteem stability on a 5-point Likert scale (score from 1 to 5, and total score varies from 5 to 25), with lower scores indicating better self-esteem stability.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Somatic problems
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A somatic problems scale modified from PHQ-15, measuring various physical discomforts and pain on a 3-point Likert scale (score from 0 to 2).
A higher score represents worse somatic problems.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Problematic Internet use
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
A 10-item problematic Internet use scale measures problematic Internet use on a 7-point Likert scale (score from 1 to 7, and total score varies from 7 to 49), with higher scores indicating greater problematic Internet use.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Adverse Childhood Experiences
Time Frame: baseline, post treatment(1 month), 3 month after post treatment
|
An adverse childhood experiences questionnaire measuring the adverse childhood experiences with 26 items.
A higher number of adverse childhood experiences represents worse childhood experiences.
|
baseline, post treatment(1 month), 3 month after post treatment
|
|
Adverse events
Time Frame: baseline, post treatment(1 month)
|
A 33-item adverse events questionnaire asks about adverse events before 18, including self-harm, experiencing emotional abuse, experiencing physical abuse, feeling severe distress, mental illness events (e.g., panic attack), and physical injury, etc.
The score of each item ranges from 0 to 1(0=no, 1=yes), 0 to 4, or 0 to 5 (a higher score indicates a more severe adverse event)
|
baseline, post treatment(1 month)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Joint Tx for Adolscents ACEs
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.